Research Society for Study of Diabetes in India
-
AstraZeneca signs MoU with Indian Diabetes Research Society RSSDI
Plans to empower one crore Indian diabetic patients by 2023 AstraZeneca India (AstraZeneca Pharma India has signed a memorandum of…
Read More »